Kaleido Biosciences Appoints Daniel Menichella as President and Chief Executive Officer
LEXINGTON, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven […]
Progenity Supports the Preeclampsia Foundation Call to Action to Accelerate Development and Adoption of Biomarker Tests for Preeclampsia
SAN DIEGO, Oct. 01, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record […]
Pennant and Scripps Health Close Joint Venture
EAGLE, Idaho, Oct. 01, 2020 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant […]
Solid Biosciences Announces FDA Lifts Clinical Hold on IGNITE DMD Clinical Trial
– Modifications to IGNITE DMD trial protocol and improvements to manufacturing processes enable continued program development –CAMBRIDGE, Mass., Oct. 01, […]
AnPac Bio Announces Equity Investment from Keystone Capital Partners for up to $7 Million
SAN JOSE, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) […]
Chiasma Announces Planned Transition of Former CEO
NEEDHAM, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company utilizing its delivery […]
ReSPECT Glioblastoma Clinical Trial Data to be Presented at 2020 Society for Neuro-Oncology Annual Meeting
AUSTIN, Texas, Oct. 01, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that its abstract regarding […]
VYNE Therapeutics Announces ZILXI™ (minocycline) topical foam, 1.5% is Available in Pharmacies Nationwide Today, October 1st
ZILXI is the First FDA Approved Minocycline Product for the Treatment of Inflammatory Lesions of Rosacea in AdultsZILXI Offers Efficacy […]
Akouos Announces Key Leadership Appointments
BOSTON, Oct. 01, 2020 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential […]
Cara Therapeutics Appoints Thomas Reilly as Chief Financial Officer
STAMFORD, Conn., Oct. 01, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing […]
